News
News

The latest updates from AFAR.

AFAR in the News: Wall Street Journal article spotlights AFAR-supported “TAME” study

Mar 17
2015

AFAR in the News: Wall Street Journal article spotlights AFAR-supported “TAME” study View MoreBACK

On March 17, 2015, AFAR and several of our experts were  featured in a Wall Street Journal article, “To Grow Old Without Disease.” Prominently featured on the cover of the Personal Journal section, the article examines the Targeting Aging with Metformin or “TAME” trial, which AFAR has helped plan and fund, and cites project leader and AFAR Deputy Scientific Director, Dr. Nir Barzilai as well as AFAR Board Members Dr. James Kirkland and Dr. S. Jay Olshansky.

The goal of the project is to implement a clinical study testing metformin, an FDA approved drug that researchers’ believe may have the ability to postpone the onset of chronic diseases associated with aging.

Read the complete article here.

Nir Barzilai, MD, is the Director of the Institute for Aging Research at Albert Einstein College of Medicine and a two-time AFAR grant recipient.

James Kirkland, MD, PhD, is the director of the Robert and Arlene Kogod Center on Aging at the Mayo Clinic and the 2012 recipient of a Glenn/AFAR Breakthroughs in Gerontology Award.

S. Jay Olshansky, PhD, is a Professor in the School of Public Health at the University of Illinois at Chicago.

For more insight into pipeline drugs that researchers believe may have to ability to postpone age-related disease check out these other recent news stories here and here.





View MoreBACK TO TOP